209 related articles for article (PubMed ID: 16875744)
1. The metabolic syndrome and nonfatal ischemic heart disease; a population-based study.
Nabipour I; Amiri M; Imami SR; Jahfari SM; Shafeiae E; Nosrati A; Iranpour D; Soltanian AR
Int J Cardiol; 2007 May; 118(1):48-53. PubMed ID: 16875744
[TBL] [Abstract][Full Text] [Related]
2. Association between electrocardiographic ischemic abnormalities and ischemic heart disease risk factors in a Japanese population.
Choudhury SR; Yoshida Y; Kita Y; Nozaki A
J Hum Hypertens; 1996 Apr; 10(4):225-34. PubMed ID: 8736453
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome according to Adult Treatment Panel III and International Diabetes Federation criteria: a population-based study.
Bener A; Zirie M; Musallam M; Khader YS; Al-Hamaq AO
Metab Syndr Relat Disord; 2009 Jun; 7(3):221-9. PubMed ID: 19320557
[TBL] [Abstract][Full Text] [Related]
4. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
[TBL] [Abstract][Full Text] [Related]
5. Impact of metabolic syndrome on ischemic heart disease - a prospective cohort study in an Iranian adult population: Isfahan Cohort Study.
Talaei M; Sadeghi M; Marshall T; Thomas GN; Kabiri P; Hoseini S; Sarrafzadegan N
Nutr Metab Cardiovasc Dis; 2012 May; 22(5):434-41. PubMed ID: 21195593
[TBL] [Abstract][Full Text] [Related]
6. Measures of obesity and metabolic syndrome in Indian Americans in northern California.
Misra KB; Endemann SW; Ayer M
Ethn Dis; 2006; 16(2):331-7. PubMed ID: 17682232
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and [corrected] hypoadiponectinemia.
Samaras K; Wand H; Law M; Emery S; Cooper D; Carr A
Diabetes Care; 2007 Jan; 30(1):113-9. PubMed ID: 17192343
[TBL] [Abstract][Full Text] [Related]
8. Metabolic syndrome in patients with ischemic heart disease.
Yasmin S; Mallick NH; Naveed T; Ali M; Noman A; Shakoor T
J Coll Physicians Surg Pak; 2008 Oct; 18(10):605-7. PubMed ID: 18940115
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of metabolic syndrome among middle aged women in Babol, Iran.
Delavar MA; Lye MS; Khor GL; Hanachi P; Hassan ST
Southeast Asian J Trop Med Public Health; 2009 May; 40(3):612-28. PubMed ID: 19842450
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
Fiuza M; Cortez-Dias N; Martins S; Belo A;
Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
[TBL] [Abstract][Full Text] [Related]
11. Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey.
Ninomiya JK; L'Italien G; Criqui MH; Whyte JL; Gamst A; Chen RS
Circulation; 2004 Jan; 109(1):42-6. PubMed ID: 14676144
[TBL] [Abstract][Full Text] [Related]
12. Metabolic syndrome and ischemic heart disease in gout.
Vázquez-Mellado J; García CG; Vázquez SG; Medrano G; Ornelas M; Alcocer L; Marquez A; Burgos-Vargas R
J Clin Rheumatol; 2004 Jun; 10(3):105-9. PubMed ID: 17043480
[TBL] [Abstract][Full Text] [Related]
13. Age-specific prevalence of the metabolic syndrome defined by the International Diabetes Federation and the National Cholesterol Education Program: the Norwegian HUNT 2 study.
Hildrum B; Mykletun A; Hole T; Midthjell K; Dahl AA
BMC Public Health; 2007 Aug; 7():220. PubMed ID: 17727697
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of metabolic syndrome in heart transplant patients: role of previous cardiopathy and years since the procedure--the TRACA study.
Cordero Fort A; Gavira JJ; Alegría-Barrero E; Castaño S; Martín A; Ubilla M; Mastrobuoni S; Alegría Ezquerra E; Herreros J; Rábago G
J Heart Lung Transplant; 2006 Oct; 25(10):1192-8. PubMed ID: 17045931
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of coronary artery disease and coronary risk factors in an urban population of Tirupati.
Latheef SA; Subramanyam G
Indian Heart J; 2007; 59(2):157-64. PubMed ID: 19122250
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of metabolic syndrome among young adults in Izmir, Turkey.
Soysal A; Demiral Y; Soysal D; Uçku R; Köseoğlu M; Aksakoğlu G
Anadolu Kardiyol Derg; 2005 Sep; 5(3):196-201. PubMed ID: 16140651
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome: an emerging public health problem in Iranian women: Isfahan Healthy Heart Program.
Sarrafzadegan N; Kelishadi R; Baghaei A; Hussein Sadri G; Malekafzali H; Mohammadifard N; Rabiei K; Bahonar A; Sadeghi M; O'Laughlin J
Int J Cardiol; 2008 Dec; 131(1):90-6. PubMed ID: 18190978
[TBL] [Abstract][Full Text] [Related]
18. Increasing number of components of the metabolic syndrome and cardiac structural and functional abnormalities--cross-sectional study of the general population.
Azevedo A; Bettencourt P; Almeida PB; Santos AC; Abreu-Lima C; Hense HW; Barros H
BMC Cardiovasc Disord; 2007 Jun; 7():17. PubMed ID: 17555566
[TBL] [Abstract][Full Text] [Related]
19. Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Rasmussen S; Ibsen H; Torp-Pedersen C; Madsbad S
J Am Coll Cardiol; 2007 May; 49(21):2112-9. PubMed ID: 17531661
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
